Rate My Professor Karl Winckel

Karl Winckel is a Secondee Lecturer in the School of Pharmacy and Pharmaceutical Sciences at the University of Queensland, Faculty of Health and Behavioural Sciences. He holds a Bachelor of Pharmacy from the University of Queensland, a Postgraduate Diploma from University College London, and a Postgraduate Diploma from Aston University. As a conjoint pharmacist, Winckel splits his time between the University of Queensland and the Princess Alexandra Hospital, where he serves as an Advanced Practice credentialed pharmacist at stage 3. His clinical pharmacy experience spans cardiology, general medicine, and care of the elderly. Winckel's primary focus is education and training; he coordinates programs for doctors, pharmacists, and nurses at the Princess Alexandra Hospital, teaches undergraduate and postgraduate clinical pharmacy courses at the University of Queensland, and co-coordinates 25-28 undergraduate student research project placements each year in the hospital's pharmacy department. He is also actively engaged in clinical education and training seminars through the Society of Hospital Pharmacists of Australia.

Winckel's research interests center on the clinical use of clozapine and anticoagulants, with his work on anticoagulant dosing in obesity contributing to updates in local guidelines. In the last five years, he has co-authored 19 journal articles and one book chapter. Notable publications include 'Effect of concurrent use of rivaroxaban or apixaban with amiodarone on international normalised ratio: a retrospective observational study' (2026, Blood Coagulation and Fibrinolysis), 'Clozapine rechallenge following myocarditis: a systematic review and rechallenge protocol' (2024, CNS Spectrums), 'The association between respiratory failure and psychotropic medications: A systematic review' (2024, Journal of Psychiatric Research), 'Antipsychotic medications and risk of respiratory failure in the respiratory high dependency unit' (2024, BJPsych Open), 'Evaluation of an interactive education workshop on hospital pharmacists' ethical reasoning: an observational study' (2024, BMC Medical Ethics), and 'Assessing drug safety assessment: metformin associated lactic acidosis' (2020 book chapter in Uncertainty in Pharmacology). Winckel has acted as Associate Advisor for Doctor of Philosophy supervisions, including completions in 2024 on the Australian Pharmacy Residency Program and in 2012 on pharmacists discussing medication beliefs to improve adherence post-myocardial infarction.